05:50 AM EDT, 10/19/2026 (MT Newswires) -- French biotechnology company Sensorion (ALSEN.PA) named Peter Weber as chief medical officer, according to a Monday release. Weber, who most recently served in the same role at Auregen BioTherapeutics, will join Sensorion on Nov. 2.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.